Dr. Dana Savici, MD

Dr. Savici practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Savici's NPI, 1184652190, was assigned on June 29, 2006. Dr. Savici holds New York license 200970.

Dr. Savici's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Savici's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Savici is also affiliated with Auburn Community Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Savici to 4 more medical groups, 3 group practices and clinics and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Savici practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Savici's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Savici is licensed in New York.

CMS data shows 342 Medicare services from Dr. Savici across 10 procedure codes in 2024, for 213 Medicare patients. Medicare paid $22,219 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 213 Medicare patients who saw Dr. Savici in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Savici's median patient age at 66, with 54% women.

In 2024, Dr. Savici wrote 821 Medicare Part D claims for 134 patients. 47% of them were for generic drugs. CMS names the drug for 708 of them, across 18 drugs with 11 or more claims each, at $206,182 in total drug cost. In 2023, CMS named 631 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Savici for performance year 2024, reported as part of a group. Dr. Savici accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Savici as offering telehealth.

Dmand AI links 3 papers to Dr. Savici, published from 2016 to 2021. Dr. Savici's most frequent co-authors are Denyse Dawn Lutchmansingh, MD and Vrinda Vyas, MBBS.

CMS Open Payments shows 15 general payments to Dr. Savici from 10 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Grifols Shared Services North America, Inc. paid the most, $90.